The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis.
Lara C BurgShenna VerheijenRuud L M BekkersJoanna IntHoutRobert W HollowaySalih TaşkınSarah E FergusonYu XueAntonino DittoGlauco BaiocchiAndrea PapadiaGiorgio BoganiAlessandro BudaRoy F P M KruitwagenPetra L M ZusterzeelPublished in: Journal of gynecologic oncology (2022)
SLN mapping with ICG is feasible with a high detection rate and negative predictive value in low- and intermediate-risk endometrial cancers. Given the incidence of SLN metastases is approximately 10% in those patients, SLN mapping may lead to stage shifting with potential therapeutic consequences. Given the high negative predictive value with SLN mapping, routine lymphadenectomy should be omitted in low- and intermediate-risk endometrial cancer.
Keyphrases
- endometrial cancer
- sentinel lymph node
- high resolution
- end stage renal disease
- high density
- ejection fraction
- lymph node
- chronic kidney disease
- newly diagnosed
- mass spectrometry
- peritoneal dialysis
- prognostic factors
- squamous cell carcinoma
- clinical practice
- patient reported outcomes
- quantum dots
- rectal cancer
- patient reported
- label free